In line with this idea, the estrogen receptor (ER)α was found to suppress breast cancer cell motility and invasion by recruiting ERK5 to the nucleus, thereby restricting the formation of an ERK5/cofilin complex in actin-rich regions of the cytoplasmic membrane [37]. Here, CFL1 is linked to breast carcinoma.